CD4+ T cell epitopes of FliC conserved between strains of Burkholderia: Implications for vaccines against melioidosis and cepacia complex in cystic fibrosis

Journal of Immunology

Volumn 193, Issue 12, 2014, Pages 6041-6049

  Musson, Julie A ^a   Reynolds, Catherine J ^b   Rinchai, Darawan ^c   Nithichanon, Arnone ^c   Khaenam, Prasong ^c   Favry, Emmanuel ^d   Spink, Natasha ^e   Chu, Karen K Y ^b   De Soyza, Anthony ^a   Bancroft, Gregory J ^e   Lertmemongkolchai, Ganjana ^c   Maillere, Bernard ^d   Boyton, Rosemary J ^b   Altmann, Daniel M ^b   Robinson, John H ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c KHON KAEN UNIVERSITY   (Thailand)

^d Institute Frederic Joliot   (France)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL VACCINE; BURKHOLDERIA PSEUDOMALLEI VACCINE; CD4 ANTIGEN; EPITOPE; FLAGELLIN; HLA ANTIGEN CLASS 2; PEPTIDE DERIVATIVE; PROTEIN FLIC; SYNAPTOPHYSIN; UNCLASSIFIED DRUG; GAMMA INTERFERON; HLA DR ANTIGEN; PEPTIDE; PROTEIN BINDING; T LYMPHOCYTE RECEPTOR;

ALLELE; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; BACTERIAL STRAIN; BINDING AFFINITY; BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA MULTIVORANS; BURKHOLDERIA PSEUDOMALLEI; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS REACTION; CYSTIC FIBROSIS; HAPLOTYPE; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; HYBRIDOMA; MACROPHAGE; MELIOIDOSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ORTHOLOGY; PROTEIN BINDING; PROTEIN PROCESSING; SEROLOGY; THAILAND; TRANSGENIC MOUSE; ANIMAL; BIOSYNTHESIS; BURKHOLDERIA; BURKHOLDERIA INFECTION; CHEMISTRY; GENETICS; IMMUNIZATION; IMMUNOLOGY; METABOLISM;

ALLELES; ANIMALS; BACTERIAL PROTEINS; BACTERIAL VACCINES; BURKHOLDERIA; BURKHOLDERIA INFECTIONS; BURKHOLDERIA PSEUDOMALLEI; CD4-POSITIVE T-LYMPHOCYTES; CROSS REACTIONS; CYSTIC FIBROSIS; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DR ANTIGENS; HUMANS; IMMUNIZATION; INTERFERON-GAMMA; MELIOIDOSIS; MICE; MICE, TRANSGENIC; PEPTIDES; PROTEIN BINDING; T-CELL ANTIGEN RECEPTOR SPECIFICITY;

EID: 84916908747     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402273     Document Type: Article

References (34)

1. Galyov, E. E., P. J. Brett, and D. DeShazer. 2010. Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis. Annu. Rev. Microbiol. 64: 495-517.
2. Rotz, L. D., A. S. Khan, S. R. Lillibridge, S. M. Ostroff, and J. M. Hughes. 2002. Public health assessment of potential biological terrorism agents. Emerg. Infect. Dis. 8: 225-230.
3. Price, E. P., D. S. Sarovich, M. Mayo, A. Tuanyok, K. P. Drees, M. Kaestli, S. M. Beckstrom-Sternberg, J. S. Babic-Sternberg, T. J. Kidd, S. C. Bell, et al. 2013. Within-host evolution of Burkholderia pseudomallei over a twelve-year chronic carriage infection. MBio 4: e00388-e13.
4. Lazar Adler, N. R., B. Govan, M. Cullinane, M. Harper, B. Adler, and J. D. Boyce. 2009. The molecular and cellular basis of pathogenesis in melioidosis: how does Burkholderia pseudomallei cause disease? FEMS Microbiol. Rev. 33: 1079-1099.
5. Chua, K. L., Y. Y. Chan, and Y. H. Gan. 2003. Flagella are virulence determinants of Burkholderia pseudomallei. Infect. Immun. 71: 1622-1629.
6. Chen, Y. S., Y. S. Hsiao, H. H. Lin, Y. Liu, and Y. L. Chen. 2006. CpG-modified plasmid DNA encoding flagellin improves immunogenicity and provides protection against Burkholderia pseudomallei infection in BALB/c mice. Infect. Immun. 74: 1699-1705.
7. Felgner, P. L., M. A. Kayala, A. Vigil, C. Burk, R. Nakajima-Sasaki, J. Pablo, D. M. Molina, S. Hirst, J. S. Chew, D. Wang, et al. 2009. A Burkholderia pseudomallei protein microarray reveals serodiagnostic and cross-reactive antigens. Proc. Natl. Acad. Sci. USA 106: 13499-13504.
8. Suwannasaen, D., J. Mahawantung, W. Chaowagul, D. Limmathurotsakul, P. L. Felgner, H. Davies, G. J. Bancroft, R. W. Titball, and G. Lertmemongkolchai. 2011. Human immune responses to Burkholderia pseudomallei characterized by protein microarray analysis. J. Infect. Dis. 203: 1002-1011.
9. Hayashi, F., K. D. Smith, A. Ozinsky, T. R. Hawn, E. C. Yi, D. R. Goodlett, J. K. Eng, S. Akira, D. M. Underhill, and A. Aderem. 2001. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410: 1099-1103.
10. Cookson, B. T., and M. J. Bevan. 1997. Identification of a natural T cell epitope presented by Salmonella-infected macrophages and recognized by T cells from orally immunized mice. J. Immunol. 158: 4310-4319.
11. + T cell responses during natural infection with Salmonella typhimurium. J. Immunol. 164: 986-993.
12. Sztein, M. B., S. S. Wasserman, C. O. Tacket, R. Edelman, D. Hone, A. A. Lindberg, and M. M. Levine. 1994. Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi. J. Infect. Dis. 170: 1508-1517.
13. +-T-cell responses generated during murine Salmonella enterica serovar Typhimurium infection are directed towards multiple epitopes within the natural antigen FliC. Infect. Immun. 73: 7226-7235.
14. Lubamba, B., B. Dhooghe, S. Noel, and T. Leal. 2012. Cystic fibrosis: insight into CFTR pathophysiology and pharmacotherapy. Clin. Biochem. 45: 1132-1144.
15. Ikpa, P. T., M. J. Bijvelds, and H. R. de Jonge. 2014. Cystic fibrosis: toward personalized therapies. Int. J. Biochem. Cell Biol. 52: 192-200.
16. De Soyza, A., A. McDowell, L. Archer, J. H. Dark, S. J. Elborn, E. Mahenthiralingam, K. Gould, and P. A. Corris. 2001. Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis. Lancet 358: 1780-1781.
17. Ratner, D., and C. Mueller. 2012. Immune responses in cystic fibrosis: are they intrinsically defective? Am. J. Respir. Cell Mol. Biol. 46: 715-722.
18. Moss, R. B., Y. P. Hsu, and L. Olds. 2000. Cytokine dysregulation in activated cystic fibrosis (CF) peripheral lymphocytes. Clin. Exp. Immunol. 120: 518-525.
19. Texier, C., S. Pouvelle, M. Busson, M. Hervé, D. Charron, A. Ménez, and B. Maillère. 2000. HLA-DR restricted peptide candidates for bee venom immunotherapy. J. Immunol. 164: 3177-3184.
20. Alexander, A. D., D. L. Huxsoll, A. R. J. Warner, Jr., V. Shepler, and A. Dorsey. 1970. Serological diagnosis of human melioidosis with indirect hemagglutination and complement fixation tests. Appl. Microbiol. 20: 825-833.
21. Romphruk, A. V., A. Romphruk, C. Kongmaroeng, K. Klumkrathok, C. Paupairoj, and C. Leelayuwat. 2010. HLA class I and II alleles and haplotypes in ethnic Northeast Thais. Tissue Antigens 75: 701-711.
22. Ito, K., H. J. Bian, M. Molina, J. Han, J. Magram, E. Saar, C. Belunis, D. R. Bolin, R. Arceo, R. Campbell, et al. 1996. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis. J. Exp. Med. 183: 2635-2644.
23. Altmann, D. M., D. C. Douek, A. J. Frater, C. M. Hetherington, H. Inoko, and J. I. Elliott. 1995. The T cell response of HLA-DR transgenic mice to human myelin basic protein and other antigens in the presence and absence of human CD4. J. Exp. Med. 181: 867-875.
24. + T cell immunity. PLoS Pathog. 10: e1004085.
25. Delvig, A. A., and J. H. Robinson. 1998. Two T cell epitopes from the M5 protein of viable Streptococcus pyogenes engage different pathways of bacterial antigen processing in mouse macrophages. J. Immunol. 160: 5267-5272.
26. Fischer, H. G., B. Opel, K. Reske, and A. B. Reske-Kunz. 1988. Granulocyte-macrophage colony-stimulating factor-cultured bone marrow-derived macrophages reveal accessory cell function and synthesis of MHC class II determinants in the absence of external stimuli. Eur. J. Immunol. 18: 1151-1158.
27. Peacock, S. J., D. Limmathurotsakul, Y. Lubell, G. C. Koh, L. J. White, N. P. Day, and R. W. Titball. 2012. Melioidosis vaccines: a systematic review and appraisal of the potential to exploit biodefense vaccines for public health purposes. PLoS Negl. Trop. Dis. 6: e1488.
28. Elborn, J. S. 2006. Practical management of cystic fibrosis. Chron. Respir. Dis. 3: 161-165.
29. Ooi, W. F., C. Ong, T. Nandi, J. F. Kreisberg, H. H. Chua, G. Sun, Y. Chen, C. Mueller, L. Conejero, M. Eshaghi, et al. 2013. The condition-dependent transcriptional landscape of Burkholderia pseudomallei. PLoS Genet. 9: e1003795.
30. + T cell responses to immunodominant epitopes correlate with disease activity of virulent Salmonella. PLoS One 7: e43481.
31. Campodónico, V. L., N. J. Llosa, M. Grout, G. Döring, T. Maira-Litrán, and G. B. Pier. 2010. Evaluation of flagella and flagellin of Pseudomonas aeruginosa as vaccines. Infect. Immun. 78: 746-755.
32. West, T. E., N. Chantratita, W. Chierakul, D. Limmathurotsakul, V. Wuthiekanun, N. D. Myers, M. J. Emond, M. M. Wurfel, T. R. Hawn, S. J. Peacock, and S. J. Skerrett. 2013. Impaired TLR5 functionality is associated with survival in melioidosis. J. Immunol. 190: 3373-3379.
33. Musson, J. A., R. Ingram, G. Durand, S. Ascough, E. L. Waters, M. G. Hartley, T. Robson, B. Maillere, E. D. Williamson, S. Sriskandan, et al. 2010. Repertoire of HLA-DR1-restricted CD4 T-cell responses to capsular Caf1 antigen of Yersinia pestis in human leukocyte antigen transgenic mice. Infect. Immun. 78: 4356-4362.
34. Dharakul, T., S. Vejbaesya, W. Chaowagul, P. Luangtrakool, H. A. Stephens, and S. Songsivilai. 1998. HLA-DR and -DQ associations with melioidosis. Hum. Immunol. 59: 580-586.